Expression of concern
From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors
Paper Information
Record ID:
20220
Author(s):
Journal:
Publication Date:
June 15, 2004
Retraction Date:
April 01, 2019
(6.6 years years ago)
Subjects:
Institution:
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OhioCountry:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/0008-5472.CAN-19-0502Additional Notes:
Ching Shih Chen has institutional misconduct finding;
Citations (239)
239
Total Citations23
Post-Retraction(9.6%)
196
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
16
After 2+ years
2102
Days since retraction (latest)
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2009
3475 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2009
3499 days before retraction
Paper citing Sensitizing Estrogen Receptor–negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Sep 2009
3499 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2009
3499 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2009
3517 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2009
3532 days before retraction
Paper citing Sensitizing Estrogen Receptor–negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Jun 2009
3591 days before retraction
Paper citing The Akt inhibitor KP372-1 suppresses Akt activity ...
Unknown Authors
Unknown Journal
Published: Jun 2009
3591 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2009
3591 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2009
3591 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2009
3591 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2009
3640 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2009
3652 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Mar 2009
3683 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Feb 2009
3711 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2009
3742 days before retraction
Paper citing Sensitizing Estrogen Receptor–negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Dec 2008
3759 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Dec 2008
3759 days before retraction
Paper citing Sensitizing Estrogen Receptor–negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Nov 2008
3790 days before retraction
Small‐Molecule Inhibitors of PDK1
Christian Peifer, Dario R. Alessi
ChemMedChem
Published: Oct 2008
119 citations
119 citations
3806 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Oct 2008
3834 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2008
3850 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2008
3926 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2008
3926 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2008
3956 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2008
3972 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2008
3987 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2008
4003 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2008
4016 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2008
4017 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Mar 2008
4034 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Feb 2008
4077 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2008
4079 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2008
4101 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2008
4108 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Nov 2007
4169 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Oct 2007
4178 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2007
4206 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2007
4230 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2007
4247 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2007
4255 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2007
4260 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2007
4292 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2007
4297 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2007
4322 days before retraction
Chemopreventive and Bioenergetic Signaling Effects of PDK1/Akt Pathway Inhibition in a Transgenic Mouse Model of Prostate Cancer
Aaron M. Sargeant, Russell D. Klein, Robert C. Rengel et al. (9 authors)
Toxicologic Pathology
Open Access
Published: Jun 2007
36 citations
36 citations
4322 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2007
4339 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2007
4353 days before retraction
Inhibition of Akt pathways in the treatment of prostate cancer
Eric C. Nelson, Christopher P. Evans, Philip C. Mack et al. (5 authors)
Prostate Cancer and Prostatic Diseases
Published: May 2007
32 citations
32 citations
4353 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2007
4366 days before retraction
Quick Stats
Total Citations:
239
Years Since Retraction:
6.6 years
Open Access:
Yes
Last Checked:
Never